Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FDL85
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $148,348
Award facts
- Contract value 100% obligated
- $148,347.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $148,347.90 by the Defense Logistics Agency (DLA) on September 16, 2025. The contract calls for the delivery of Entyvio 300 mg vials, a biologic medication used to treat inflammatory bowel disease, with an ultimate completion date of October 7, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its small business status.
This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with the DLA valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts for branded and generic prescription drugs, biologics, and specialty medications. The Park Ridge, Illinois location serves as the place of performance for this delivery order, reinforcing the company's role as a primary distributor of essential pharmaceutical products to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FDL85?
SPE2DB25FDL85 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FDL85 worth?
The government has obligated $148,348 on SPE2DB25FDL85.
Is contract SPE2DB25FDL85 an order under another contract?
Yes. SPE2DB25FDL85 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL85 competed?
The extent of competition for SPE2DB25FDL85 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award